[go: up one dir, main page]

SE0402976L - Medicinsk produkt - Google Patents

Medicinsk produkt

Info

Publication number
SE0402976L
SE0402976L SE0402976A SE0402976A SE0402976L SE 0402976 L SE0402976 L SE 0402976L SE 0402976 A SE0402976 A SE 0402976A SE 0402976 A SE0402976 A SE 0402976A SE 0402976 L SE0402976 L SE 0402976L
Authority
SE
Sweden
Prior art keywords
medical product
container
dose
optionally
inhalation
Prior art date
Application number
SE0402976A
Other languages
English (en)
Other versions
SE0402976D0 (sv
Inventor
Thomas Nilsson
Sven Calander
Alf Niemi
Claes Friberg
Lars Kax
Mattias Myrman
Original Assignee
Mederio Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mederio Ag filed Critical Mederio Ag
Priority to SE0402976A priority Critical patent/SE0402976L/sv
Publication of SE0402976D0 publication Critical patent/SE0402976D0/sv
Priority to US11/049,696 priority patent/US20060120969A1/en
Priority to EP05801482A priority patent/EP1827381A1/en
Priority to CA002589118A priority patent/CA2589118A1/en
Priority to ZA200705376A priority patent/ZA200705376B/xx
Priority to AU2005310367A priority patent/AU2005310367A1/en
Priority to MX2007006533A priority patent/MX2007006533A/es
Priority to BRPI0518600-5A priority patent/BRPI0518600A2/pt
Priority to KR1020077015300A priority patent/KR20070095927A/ko
Priority to CNA2005800476483A priority patent/CN101111226A/zh
Priority to RU2007124795/15A priority patent/RU2007124795A/ru
Priority to JP2007544302A priority patent/JP2008521893A/ja
Priority to PCT/SE2005/001648 priority patent/WO2006059939A1/en
Priority to US11/272,859 priority patent/US20060239933A1/en
Publication of SE0402976L publication Critical patent/SE0402976L/sv
Priority to IL183623A priority patent/IL183623A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Packages (AREA)
SE0402976A 2004-12-03 2004-12-03 Medicinsk produkt SE0402976L (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE0402976A SE0402976L (sv) 2004-12-03 2004-12-03 Medicinsk produkt
US11/049,696 US20060120969A1 (en) 2004-12-03 2005-02-04 Medical product for inhalation containing glucagon-like peptide-1 (GLP-1)
PCT/SE2005/001648 WO2006059939A1 (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
MX2007006533A MX2007006533A (es) 2004-12-03 2005-11-02 Un producto medico que comprende un medicamento peptidico tipo glucagon pretendido para inhalacion pulmonar.
CNA2005800476483A CN101111226A (zh) 2004-12-03 2005-11-02 包含预期用于肺吸入的胰高血糖素样肽药物的医学产品
ZA200705376A ZA200705376B (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
AU2005310367A AU2005310367A1 (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
EP05801482A EP1827381A1 (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
BRPI0518600-5A BRPI0518600A2 (pt) 2004-12-03 2005-11-02 produto mÉdico compreendendo um medicamento de peptÍdeo tipo glucagon, idealizado para inalaÇço pulmonar
KR1020077015300A KR20070095927A (ko) 2004-12-03 2005-11-02 폐 흡입을 위한 글루카곤-형 펩타이드 약제를 포함하는의약품
CA002589118A CA2589118A1 (en) 2004-12-03 2005-11-02 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
RU2007124795/15A RU2007124795A (ru) 2004-12-03 2005-11-02 Медицинский продукт, содержащий лекарственное средство на основе глюкагоноподобного пептида, предназначенное для легочной ингаляции
JP2007544302A JP2008521893A (ja) 2004-12-03 2005-11-02 肺吸入用のグルカゴン様ペプチド薬物を含む医療品
US11/272,859 US20060239933A1 (en) 2004-12-03 2005-11-15 Medical product
IL183623A IL183623A0 (en) 2004-12-03 2007-06-03 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0402976A SE0402976L (sv) 2004-12-03 2004-12-03 Medicinsk produkt

Publications (2)

Publication Number Publication Date
SE0402976D0 SE0402976D0 (sv) 2004-12-03
SE0402976L true SE0402976L (sv) 2006-06-04

Family

ID=33550603

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0402976A SE0402976L (sv) 2004-12-03 2004-12-03 Medicinsk produkt

Country Status (9)

Country Link
US (2) US20060120969A1 (sv)
JP (1) JP2008521893A (sv)
CN (1) CN101111226A (sv)
BR (1) BRPI0518600A2 (sv)
IL (1) IL183623A0 (sv)
MX (1) MX2007006533A (sv)
RU (1) RU2007124795A (sv)
SE (1) SE0402976L (sv)
ZA (1) ZA200705376B (sv)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4713798B2 (ja) 1999-06-29 2011-06-29 マンカインド コーポレイション ペプチドおよびタンパク質の薬学的因子の精製および安定化
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
SI1494732T1 (sl) 2002-03-20 2008-08-31 Mannking Corp Inhalacijski aparat
US20080260838A1 (en) * 2003-08-01 2008-10-23 Mannkind Corporation Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US8921311B2 (en) 2003-08-01 2014-12-30 Mannkind Corporation Method for treating hyperglycemia
AU2005277208B2 (en) 2004-08-20 2011-11-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
DK1791542T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for pharmaceutical delivery
SE0402976L (sv) * 2004-12-03 2006-06-04 Mederio Ag Medicinsk produkt
KR101486397B1 (ko) 2005-09-14 2015-01-28 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
AU2007216966C1 (en) 2006-02-22 2014-03-20 Mannkind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
AU2008316636B2 (en) * 2007-10-24 2014-02-06 Mannkind Corporation Delivery of active agents
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
KR101736535B1 (ko) * 2007-10-24 2017-05-16 맨카인드 코포레이션 Ｇｌｐ-1에 의한 유해 효과의 예방 방법
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN109568740B (zh) 2008-06-13 2022-05-27 曼金德公司 干粉吸入器和用于药物输送的系统
BRPI0914308B8 (pt) 2008-06-20 2021-06-22 Mannkind Corp sistema de inalação
EP4074327A1 (en) * 2008-06-27 2022-10-19 Duke University Therapeutic agents comprising elastin-like peptides
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
LT3228320T (lt) 2008-10-17 2020-03-10 Sanofi-Aventis Deutschland Gmbh Insulino ir glp-1 agonisto derinys
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
MX2011007371A (es) 2009-01-08 2011-09-06 Mannkind Corp Metodo para tratar la hiperglucemia con la molecula.
EP4578502A3 (en) 2009-02-26 2025-10-08 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
EP2405963B1 (en) 2009-03-11 2013-11-06 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
MY186975A (en) 2009-06-12 2021-08-26 Mannkind Corp Diketopiperazine microparticles with defined specific surface areas
JP5801997B2 (ja) * 2009-07-07 2015-10-28 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器
WO2011017554A2 (en) 2009-08-07 2011-02-10 Mannkind Corporation Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
PE20121362A1 (es) 2009-11-13 2012-10-17 Sanofi Aventis Deutschland Composicion farmaceutica que comprende despro36exendina-4(1-39)-lys6-nh2, insulina gly(a21)-arg(b31)-arg(b32) y metionina
US20110118178A1 (en) * 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin
KR101772372B1 (ko) 2009-11-13 2017-08-29 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
BR112012023407A2 (pt) * 2010-03-31 2019-09-24 Glenmark Pharmaceuticals Ltd composição em pó farmacêutica para instalação, e, processo para a preparação da mesma.
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
EP2611458B1 (en) 2010-08-30 2016-09-21 Sanofi-Aventis Deutschland GmbH Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
DK2694402T3 (en) 2011-04-01 2017-07-03 Mannkind Corp BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012300978B2 (en) 2011-08-29 2017-04-27 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
ES2754388T3 (es) 2013-03-15 2020-04-17 Mannkind Corp Composiciones y métodos de dicetopiperazina microcristalina
EP3021834A1 (en) 2013-07-18 2016-05-25 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
US20150038674A1 (en) * 2013-08-05 2015-02-05 Bayrak Bertan Boran Use of glp-2 analogues in pulmonary diseases for therapeutic purpose
WO2015148905A1 (en) * 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
HRP20230470T1 (hr) 2014-12-12 2023-07-21 Sanofi-Aventis Deutschland Gmbh Formulacija fiksnog omjera inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
TW201726200A (zh) 2016-01-11 2017-08-01 塞坤醫藥有限公司 個人化蒸發裝置
WO2023224577A1 (en) * 2022-05-18 2023-11-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising micronized human insulin
CN115192554A (zh) * 2022-08-08 2022-10-18 浙江仙琚萃泽医药科技有限公司 无抛射剂的含肽吸入溶液剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409496D0 (en) * 1994-05-12 1994-06-29 London Health Ass Method for improving glycaemic control in diabetes
US6720407B1 (en) * 1998-08-28 2004-04-13 Eli Lilly And Company Method for administering insulinotropic peptides
FI108518B (sv) * 1999-04-23 2002-02-15 Orion Yhtymae Oyj Pulverinhalator för kombinationsmedicin
US6528486B1 (en) * 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
US20010012829A1 (en) * 2000-01-11 2001-08-09 Keith Anderson Transepithelial delivery GLP-1 derivatives
US7186683B2 (en) * 2000-09-18 2007-03-06 Sanos Bioscience A/S Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
SE0101233L (sv) * 2001-04-05 2002-10-01 Microdrug Ag Förfarande och anordning för frigörande av pulver och inhalatoranordning för administrering av medicinskt pulver
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
SE0402976L (sv) * 2004-12-03 2006-06-04 Mederio Ag Medicinsk produkt

Also Published As

Publication number Publication date
JP2008521893A (ja) 2008-06-26
US20060239933A1 (en) 2006-10-26
RU2007124795A (ru) 2009-01-10
BRPI0518600A2 (pt) 2008-11-25
SE0402976D0 (sv) 2004-12-03
ZA200705376B (en) 2008-12-31
US20060120969A1 (en) 2006-06-08
MX2007006533A (es) 2007-08-02
CN101111226A (zh) 2008-01-23
IL183623A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
SE0402976L (sv) Medicinsk produkt
BRPI0417155A (pt) produto medicinal compreendendo tiotrópio em um recipiente à prova de umidade
MY187036A (en) Inhalation device and method
CY1110636T1 (el) Προ-δοσιμετρημενος εισπνευστηρας ξηρης σκονης για φαρμακα ευαισθητα στην υγρασια
WO2012041938A3 (en) Inhaler
MX371521B (es) Sistema de inhalacion de polvo seco.
MX2010008234A (es) Nueva dosificacion y formulacion.
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
CA2791847A1 (en) An improved dry powder drug delivery system
CY1110625T1 (el) Μεθοδος για την χορηγηση τιοτροπιου
SE0402345L (sv) Uppmätt läkemedelsdos
SE0401612L (sv) Inhalator som använder balja
JP2004533438A5 (sv)
AR094287A1 (es) Metodos y composiciones para administracion de oxibutinina
Skyler Pulmonary insulin update

Legal Events

Date Code Title Description
NAV Patent application has lapsed
NAV Patent application has lapsed